Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 23

Scalable Capital mounts $58m series D campaign

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

Jul 23, 2020

Dexterity has a knack for funding

Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.

Jul 23, 2020

Cerevance captures $65m series B

UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.

Jul 22, 2020

Spin Memory executes extra series B cash

NYU-founded Spin Memory has now raised $60.3m in series B capital, having lured the return of Allied Minds, Arm and Applied Ventures.

Jul 20, 2020

Glympse Bio gleans series B funding

Section 32 has led a $46.7m series B round that will support further development of the MIT spinout's biosensor-based diagnostics device.

Jul 17, 2020

Paige pings investors for extra series B cash

Memorial Sloan Kettering spinout Paige’s series B total stands at $70m following a third tranche featuring Goldman Sachs and Healthcare Venture Partners.

Jul 13, 2020

Nine Square sides with ATP for $50m series A

UCSF has unveiled Nine Square Therapeutics with $50m in series A capital from founding investor Apple Tree Partners.

Jul 7, 2020

Evidation Health generates $45m results

McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m five years after being co-founded by Stanford Health Care.

Jul 3, 2020

XSky stores $45.3m series D

Cloud storage provider XSky pushed its funding haul to $38m after securing the return of a Tsinghua University's fund management affiliate.

Jul 3, 2020

Bolt latches onto $93.5m series C

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Jul 2, 2020

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here